Esperion Therapeutics
ESPR
#8313
Rank
โ‚ฌ0.14 B
Marketcap
0,75ย โ‚ฌ
Share price
-9.27%
Change (1 day)
-58.21%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2024 (TTM): โ‚ฌ6.88 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are โ‚ฌ0.33 Billion. , an increase over its 2023 earnings that were of -โ‚ฌ0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 โ‚ฌ6.51 M-104.99%
2023 -โ‚ฌ0.14 Billion-15.03%
2022 -โ‚ฌ0.16 Billion-20.61%
2021 -โ‚ฌ0.2 Billion84.28%
2020 -โ‚ฌ0.11 Billion35.75%
2019 -โ‚ฌ77.31 Million-55.71%
2018 -โ‚ฌ0.18 Billion19.57%
2017 -โ‚ฌ0.15 Billion125.39%
2016 -โ‚ฌ64.77 Million51.43%
2015 -โ‚ฌ42.78 Million36.45%
2014 -โ‚ฌ31.35 Million43.55%
2013 -โ‚ฌ21.84 Million145.26%
2012 -โ‚ฌ8.91 Million
2002 -โ‚ฌ25.39 Million-7.81%
2001 -โ‚ฌ27.54 Million15.03%
2000 -โ‚ฌ23.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.44 Billion-6,821.89%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.47 B 7,117.73%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.64 B 147,954.89%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ4.14 B 63,581.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ24.97 Million-483.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.18 Billion-2,769.90%๐Ÿ‡บ๐Ÿ‡ธ USA